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Besides the potential effect of hypoxia on O 2 transport during recovery, some adaptative mechanisms that occur within a few days at high altitude may impair performance during repeated sprints: 1) the decrease in buffer capacity resulting from the compensation of respiratory alkalosis (24) may lead to a more severe acidosis after the sprint and, therefore, limit the restoration of power output, and 2) the early decline in plasma volume (26) may interfere with recovery processes at high altitude, because the sprint itself induces a severe hemoconcentration during recovery (11) . The present study, therefore, examines the effect of prolonged exposure to hypoxia on the restoration of muscle power during recovery. High-altitude experiments were conducted 5-6 days after arrival at 4,350 m. At that time, the changes in acid-base status and plasma volume had reached a steady-state level (24) , and any effects of symptoms of acute mountain sickness on performance during sprint were avoided.
METHODS
Subjects. Seven healthy volunteers (5 men, 2 women) served as subjects. Each subject underwent a medical examination and was fully informed about the possible risks of the experimental procedures. Informed consent was obtained from each subject. The study was approved by the Ethics Committee at the Necker Hospital, Paris, France. All subjects were moderately trained sea-level residents, who were not acclimatized to altitude before the experiments. Their age, height, and body mass (mean 6 SD) were 29 6 5 yr, 174 6 9 cm, and 65 6 7 kg, respectively. The two women were in the first phase of their menstrual cycles during both normoxic and hypoxic experiments.
Procedures. All experiments were conducted on a mechanically braked cycle ergometer (Monark 864) during a first week at sea level (50 m, barometric pressure 5 761 6 6 mmHg), then a week later at a field laboratory on Mont Blanc (Observatoire Vallot; 4,350 m, barometric pressure 5 452 6 1 mmHg). After a night spent in Chamonix (1,000 m), the subjects were transported by helicopter within 10 min to 4,350-m altitude. During the whole study, the level of activity of the subjects remained low, and the temperature in the observatory was kept constant at 20-23°C. Maximal O 2 uptake (V O 2 max ) was determined on the ergometer at sea level and on days 3-4 after arrival at high altitude. The test protocol involved a 4-min warm-up at 60 W, followed by an incremental exercise (30 W every 2 min) until the subject could not keep up the pedaling rate [60 revolutions/min (rpm)]. Each subject performed a preliminary force-velocity test (22) by pedaling maximally during 5 s against loads from 2 to 10 kg to calculate the individual optimal braking load for the Wingate test (WT). The force-velocity relationship was determined at sea level only, and the same braking load was used for normoxic and hypoxic WT experiments. In this study, WT was a 20-s cycle exercise with maximal voluntary pedaling rate. Before each supramaximal test, subjects performed a 5-min warm-up at 60-90 W. During all WT and forcevelocity tests, subjects remained seated on the saddle and were encouraged vigorously. The subjects were trained for WT before the experiments.
The frequency of revolutions was recorded from a Halleffect magnet fixed on the wheel and a solenoid fixed to the fork of the ergometer in front of a point of the magnet trajectory. The power output was calculated for each cycle from the instant wheel velocity (V; in rpm). Peak power output (PPO) and mean power output (MPO) were obtained by the following equations: PPO 5 V max 3 L/3.746 and MPO 5 V mean 3 L/3.746, where V max is maximal velocity averaged over a selected 2-s interval; V mean is mean velocity over 20 s; L is braking load in kilograms, and 3.746 is the gearing of the ergometer. A fatigue index was calculated from the ratio V max /V end , where V end is velocity averaged over the last 2 s of exercise.
The protocol developed for this experiment consisted of two successive 20-s WT (WT1 and WT2), with a 5-min passive recovery period in between, with the subject remaining seated on the ergocycle. Before the test, the subjects performed a 5-min warm-up at 60-90 W, followed by 10 min of rest on the ergocyle. After completion of WT2, a 14-min passive recovery on the ergocycle was monitored. After an overnight fast, the subjects performed this procedure at sea level and again on days 5-6 after arrival at 4,350 m. A polyethylene catheter was inserted into an antecubital vein. All subjects were free of symptoms of acute mountain sickness at the time of WT at high altitude.
Gas exchange. Gas exchange was recorded breath by breath at rest, during exercise, and during recovery by using an integrated computer system (CPX/D cardiopulmonary exercise system; Medical Graphics, Minneapolis, MN). Expired airflow was measured by a symmetrically disposed Pitot tube flowmeter. This device measured minute ventilation (V E) from two sensitive differential pressure transducers with a precision of 2% for flows ranging from 6 to 172 l/min (17) . The gas analyzers were part of the integrated system and consisted of a galvanic fuel cell for measurement of O 2 concentration and an infrared CO 2 analyzer. A reference gas bottle containing 12.1% O 2 and 5.2% CO 2 was used for the calibration of the analyzer. The delay time, response time to 90% of final value, and precision were 0.54 s, 0.08 s, and 0.03% for the O 2 analyzer and 0.57 s, 0.11 s, and 0.05% for the CO 2 analyzer, respectively. The breath-by-breath measurements of V E and V O 2 were averaged over a 2-min interval at rest. Heart rate (HR) was measured continuously, as well as arterial O 2 saturation (Sa O 2 ) by an ear pulse oximeter (Biox II, Ohmeda). Mean arterial pressure (MAP) was collected over 20-s time intervals during recovery by an automatic sphygmomanometer (Dinamap 1846 SX P, Critikon). Resting values for MAP were recorded as the mean of three successive measurements.
Blood analyses. Capillary blood from a prewarmed earlobe was sampled at rest (R), 1.5 min after WT1 (R1 1.5 min ), 1.5 min after WT2 (R2 1.5 min ), and 10 min after WT2 (R2 10 min ) and then immediately analyzed in a blood-gas apparatus (Ciba Corning, model 248) for pH, bicarbonate concentration ([HCO 3 2 ]), and O 2 and CO 2 pressure and content (PO 2 and PCO 2 ; CO 2 and CCO 2 , respectively). To collect blood anaerobically and to ensure a valid PO 2 , a puncture was made with a microlance for each sample. Consequently, each experiment required four earlobe punctures. Simultaneously, forearm venous blood samples were collected in heparinized tubes and immediately centrifuged. The separated plasma was stored in liquid nitrogen within 30 min for subsequent analyses. Concentrations of potassium ( (12) . Resting venous samples were used for the determination of hemoglobin concentration and hematocrit by micromethod.
Blood velocity measurements. The blood velocity in the right common femoral artery (FBV) was monitored during rest and recovery by a continuous Doppler ultrasound method. The frequency of the apparatus was 4 MHz. The probe was located ,3-6 cm distal of the inguinal ligament and positioned on the skin with an adhesive strip. The probe was 7 mm thick and inserted into a flat plastic plate (82 3 38 mm). Because of muscle and skin movements during WT, FBV could not be recorded during exercise, but only at rest and during recovery. However, the probe characteristics ensured a correct position between the transducer and the skin surface before and after exercise, with a constant angle between the transducer and the femoral artery, provided that the subject remained in the reference position during measurements (i.e., seated motionless on the ergometer with the trunk and the right leg in a vertical axis). The angle between the transducer and the probe surface was 54°. Because the continuous ultrasound method does not take into account any sample volume, only forward velocity was measured during recovery to avoid femoral venous artifacts. The intra-and intersubject variability of this method were tested in our laboratory during a separate experiment. The coefficients of variation were 11.6% (intra-) and 127% (inter-) for peak FBV immediately after exercise (unpublished data). The site of recording was marked on the thigh with a pencil during the experiments at sea level and served as reference for the recordings at 4,350 m. Instantaneous FBV was displayed from a 30-Hz sampling frequency and averaged over each cardiac cycle for analysis. FBV monitoring was stopped at 4.5 min after WT1 so that subjects could prepare themselves for WT2. FBV analysis started at 10 s after the end of each WT and stopped at 4.5 and 6.5 min after the end of WT1 and WT2, respectively.
Calculations. Accumulated O 2 deficit during each 20-s exercise was calculated by a method described previously (16 ) . O 2 deficit, EPOC 5 min and VE 5 min were calculated from breath-by-breath values. An index of total peripheral resistance (TPR index ) was calculated by the ratio between MAP and FBV. Finally, the rate of FBV decrease over the first 4.5 min of recovery after each bout was estimated by the half-time decrease (t 1/2 FBV) from the end-exercise value to that at 4.5 min of recovery.
Statistics. Data are means 6 SD. A two-way analysis of variance with repeated measures was performed to make comparisons between 1) altitude conditions and across time for gas exchange, cardiovascular data, and blood samples, and 2) altitude conditions and exercise bouts for power measurements and calculated data. A Dunnett's test was used for multiple comparisons (9) . Linear regressions were performed by using the least squares method. The two regression lines obtained at sea level and at 4,350 m were compared by analysis of multiple linear regression (9) . Recovery V O 2 data were fitted for each subject by using nonlinear least squares regression to a monoexponential model (8) . The t 1/2 decrease was used to indicate the rate of decrease of V O 2 . Significant differences were accepted at P , 0.05.
RESULTS
V O 2 max . V O 2 max decreased by 29% from 55 6 6 ml· min 21 ·kg 21 at sea level to 38 6 7 ml · min 21 ·kg 21 at 4,350 m.
Hematology. Resting hemoglobin concentration and hematocrit increased from 13.8 6 1.6 g/dl and 39.4 6 3.3% at sea level to 15.6 6 1.7 g/dl (P , 0.01) and 45.3 6 3.7% (P , 0.001) at 4,350 m, respectively.
Mechanical power. High altitude had no effect on MPO during WT1. A significant decrease in MPO occurred between WT1 and WT2 (6.9% at sea level and 10.7% at high altitude; Table 1 ). High altitude did not lead to a larger decrease in MPO between WT1 and WT2. The diminution in PPO between the two WT was significant at high altitude (P , 0.05) but not at sea level.
Gas exchange. V O 2 peak was significantly lower at 4,350 m over 0-40 s after WT1 and WT2, with no difference observed later in recovery (Table 2, Fig. 1A ). V O 2 remained above the resting level throughout the 14 min of recovery after WT2 at both sea level and high altitude. The rate of decrease of V O 2 after both tests was faster in sea level than in high altitude; t 1/2 was 38 6 8 and 36 6 6 s at sea level, and 45 6 7 (P , 0.05) and 45 6 8 s (P , 0.05) at high altitude, after WT1 and WT2, respectively. Resting V E was higher at high altitude (P , 0.01). V E was increased at high altitude during the whole recovery interval studied after each WT (Fig.  1B) . In both conditions, peak V E was higher after WT2 than after WT1. V E remained above resting level throughout the 14 min of recovery after WT2 at sea level and high altitude. Hypoxic exercise induced an additional decrease in Sa O 2 below resting level during recovery, between 30 and 60 s after WT1 and 10-150 s after WT2 (Fig. 1C) . The decrease in O 2 deficit between WT1 and WT2 (Table 1 ) was 16% at high altitude (P , 0.01) and 8% at sea level (P 5 0.05). A slight but not significant diminution in EPOC 5 min was observed in hypoxia, and VE 5 min was higher at 4,350 m than at sea level throughout both recovery periods (Table 1) .
Cardiovascular variables. Peak FBV after WT1 and WT2 was 54 6 9 and 58 6 9 cm/s at sea level, 50 6 10 and 53 6 12 cm/s at high altitutde, respectively (Table  3) . Peak FBV did not differ between sea level and high altitude. FBV was lower at high altitude than at sea level (P , 0.05) between 1 and 4.5 min after WT1 and between 30 s and 2 min after WT2. The t 1/2 FBV was not modified by high altitude. The t 1/2 FBV after WT1 and WT2 was 28 6 12 and 53 6 20 s at sea level, 30 6 9 and 64 6 41 s at high altitude, respectively. Hypoxia did not induce any alteration in MAP throughout recovery; and, finally, TPR index was not modified at high altitude.
Blood gases. The decrease in pH induced by each WT was larger at high altitude than at sea level (Table 4) . pH decreased between rest and R1 1.5 min by 0.145 6 0.039 at sea level and 0.201 6 0.063 at high altitude (P , 0.01). pH decreased between R1 1.5 min and R2 1.5 min by 0.077 6 0.035 at sea level and 0.137 6 0.057 at high altitude (P , 0.05). [HCO 3 2 ] was lower at high altitude than at sea level at rest and during both recovery periods. Arterial CO 2 and PO 2 , as well as CCO 2 and PCO 2 were lower at high altitude than at sea level. (Fig. 2) .
The relationship between total work and hydrogen ion [H 1 ] accumulation was not altered in high altitude (Fig. 3) , although the increase in [H 1 ] was greater at 4,350 m (P , 0.001). The same plasma lactate accumulation at sea level and at high altitude was associated with a greater increase in [H 1 ] (P , 0.001) and a greater increase in [NE] (P , 0.01) at 4,350 m (Fig. 4) 
DISCUSSION
The primary finding of this study was that 5-6 days of exposure to 4,350 m did not reduce mechanical performance during a repeated supramaximal 20-s cycle exercise. We demonstrated that prolonged exposure to hypoxia did not impair the restoration of muscle Restoration of power output. The restoration of power output was not significantly impaired by prolonged exposure to high altitude. The present study did not include any additional experiment in acute hypoxia; therefore, we were not able to analyze the effect of acclimatization per se on performance. However, in previous experiments with the same exercise model, we observed that acute hypoxia (fractional inspired O 2 5 0.115) had no effect on performance during repeated Values are means 6 SD. Mean values of heart rate (HR; n 5 7), femoral blood velocity (FBV; n 5 6), mean arterial pressure (MAP; n 5 7), and index of total peripheral resistance [TPR index (MAP/FBV); n 5 6] were given at rest (R), 1.5 min after WT1 (R1 1.5 min ), 1.5 min after WT2 (R2 1.5 min ), and 6.5 min after WT2 (R2 6.5 min ). * P , 0.05, significantly different from N. † P , 0.05; ‡ P , 0.01, significantly different from rest. ) were measured at rest, 1.5 min after WT1 (R1 1.5 min ), 1.5 min after WT2 (R2 1.5 min ), and 10 min after WT2 (R2 10 min ). * P , 0.05; † P , 0.01, significantly different from N. ‡ P , 0.05; § P , 0.01, significantly different from rest. Taken together, these data and the present results suggest that acclimatization does not cause any enhancement in performance, because the decrease in muscle power between both tests tended to be greater after prolonged exposure to high altitude.
Accumulated O 2 deficit can be used as a measure of anaerobic energy release (16) . The decrease in accumulated O 2 deficit between both tests was significant only at high altitude, which suggests that total anaerobic ATP turnover was further reduced during the second sprint at high altitude. However, the decrement in MPO during WT2 tended to be higher at high altitude, although the difference did not reach signifiance. Considering the small number of subjects (n 5 7), a type 1 statistical error cannot be excluded, which means that prolonged exposure to high altitude would impair muscle power during repeated sprints. Alternatively, our data may indicate that the recovery of power output is not altered by prolonged hypoxia, although this restoration is associated with the resynthesis of phosphocreatine and the recovery of the glycolytic rate to its initial level, both of which are O 2 -dependent processes (1, 7) .
V O 2 during recovery after sprint. The slight decrease in EPOC during recovery between both exercise bouts at high altitude (14%, NS) was entirely due to a large reduction in V O 2 at high altitude in the first minute after exercise. Furthermore, the 30-40% decrease in V O 2 peak after exercise occurred at a time when ventilation was 20% higher at high altitude. It is tempting to speculate that the difference observed in V O 2 peak response reflects a limitation in peak leg V O 2 at 4,350 m. This hypothesis is supported by the finding that maximal leg V O 2 is reduced in hypoxia because of a decrease in leg O 2 delivery but no increase in muscle O 2 -diffusive capacity (20) . Immediately after sprint, it is likely that peak leg V O 2 (and muscle O 2 diffusion) was also near maximum, so that a reduced leg O 2 supply induced a transient limitation in leg V O 2 . The hypothesis of a lower leg O 2 delivery after sprint at 4,350 m was supported by the present data. On one hand, we observed a marked decrease in arterial Sa O 2 within the first minute after sprint and a decrease in arterial O 2 content at 4,350 m. On the other hand, the present Doppler ultrasound measurements, which were in accordance with others' studies (10, 23) , provide some information with respect to alterations in femoral blood flow. We found no increase in peak FBV after sprint at high altitude. Nevertheless, the fact that we found no relationship between the kinetics of V O 2 (t 1/2 V O 2 ) and FBV (t 1/2 FBV) during recovery suggests that the V O 2 response after sprint does not depend only on leg blood flow. Finally, the increase in plasma [protein] during recovery after sprint at 4,350 m indicates that sprintinduced hemoconcentration was larger after prolonged exposure to high altitude. Thus an increased blood viscosity may be involved in the transient limitation in V O 2 peak at 4,350 m via a limitation of O 2 -diffusion processes at the muscular level.
The fact that [La 2 ] during recovery was not altered at high altitude was consistent with the performance data. The higher exercise-induced acidosis at 4,350 m related to the same plasma lactate accumulation in both altitude conditions (Fig. 4A) could be linked to the decrease in [HCO 3 2 ], as has been shown in acclimatized lowlanders (25) . The decrease in buffer capacity at 4,350 m may also explain that the regression line between performance and acidosis was shifted to a higher level of H 1 accumulation at 4,350 m (Fig. 3) . Nevertheless, the changes in acid-base balance observed at high altitude were not associated with an impairment in muscle power during repeated sprints. High altitude also induced a larger increase in catecholamine response during recovery, which may reflect a greater sympathetic nervous activity. Considering that catecholamines are known to activate muscle glycogenolysis (5, 13), the same plasma lactate accumulation in both altitude conditions, related to a higher NE response at high altitude (Fig. 4B) , may, therefore, reflect a desensitization of muscle b-adrenoceptors in response to permanent high adrenergic activity at 4,350 m, as shown in heart b-adrenoceptors with similar altitude conditions (18) .
In summary, the repetition of supramaximal exercise after a prolonged exposure to high altitude was associated with several changes observed during recovery, such as transient decreases in arterial Sa O 2 and V O 2 , higher acidosis, hemoconcentration, and catecholamine response, and finally, no change in blood lactate accumulation. At high altitude, the same blood lactate accumulation was related to a higher adrenergic activity. However, these changes were not associated with any significant impairment of the restoration of muscle power.
